Evidence map›Paper›PMID 35222906›Full record

ReviewChemical science2022

Asymmetric transformations from sulfoxonium ylides.

Clarice A D Caiuby, Lucas G Furniel, Antonio C B Burtoloso

Abstract readReview
In one paragraph

Review in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Synthesis ofChemical communications (Cambridge, England) · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Dearomatization of benzopyrylium triflates with sulfoxonium ylides.Chemical communications (Cambridge, England) · 2022
    Article
  19. Article
  20. Synthesis of INature communications · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Clarice A D CaiubySão Carlos Institute of Chemistry, University of São Paulo São Carlos SP CEP 13560-970 Brazil antonio@iqsc.usp.br.ORCID https://orcid.org/0000-0002-5037-3281
Lucas G FurnielSão Carlos Institute of Chemistry, University of São Paulo São Carlos SP CEP 13560-970 Brazil antonio@iqsc.usp.br.
Antonio C B BurtolosoSão Carlos Institute of Chemistry, University of São Paulo São Carlos SP CEP 13560-970 Brazil antonio@iqsc.usp.br.ORCID https://orcid.org/0000-0003-2203-1556

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sulfoxonium ylides are important surrogates for diazo compounds, and their use in industry as safer alternatives has been evaluated during recent years. Beyond the known classical transformations, these ylides have also been used in a surprising plethora of novel and intrinsic chemical reactions, especially in recent years. Bench stability and handling are also an advantage of this class of organosulfur molecules. Despite this, efficient asymmetric transformations, specifically catalytic enantioselective versions, have only recently been reported, and there are specific reasons for this. This perspective article covers this topic from the first studies up to the latest advances, giving personal perspectives and showing the main challenges in this area in the coming years.

Identifiers

PMID35222906
PMCPMC8809404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.